K. Bogeso

发表

A Stereoselective Pharmacophoric Model of the Serotonin Re‐uptake Site

K. Gundertofte, K. Bogeso, T. Liljefors, 2007 .

Structure–activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5‐HT transporter

K. Bogeso, U. Gether, M. Larsen, 2016, British journal of pharmacology.

Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers

K. Bogeso, J. Larsen, J. Hyttel, 2004, Psychopharmacology.

Effects of S (+)-3-phenethyl-PP, a putative dopamine autoreceptors agonist with greater autoreceptor selectivity than 3-PPP enantiomers.

K. Bogeso, J. Larsen, J. Hyttel, 1984, European journal of pharmacology.

3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake.

K. Bogeso, T. Liljefors, J. Hyttel, 1985, Journal of medicinal chemistry.

Preliminary studies on the absorption, distribution, metabolism, and excretion of THIP in animal and man using 14C-labelled compound.

K. Bogeso, A. Jørgensen, T. Aaes-Jørgensen, 2009, Acta pharmacologica et toxicologica.

The neuropharmacological profile of tefludazine, a potential antipsychotic drug with dopamine and serotonin receptor antagonistic effects

K. Bogeso, J. Larsen, J. Hyttel, 1986 .

Synthesis and muscarinic receptor pharmacology of a series of 4,5,6,7-tetrahydroisothiazolo[4,5-c]pyridine bioisosteres of arecoline.

K. Bogeso, P. Krogsgaard‐Larsen, H. Bräuner‐Osborne, 1999, Bioorganic & medicinal chemistry.

Homology Modeling of the Serotonin Transporter: Insights into the Primary Escitalopram‐binding Site

K. Gundertofte, K. Bogeso, G. Peters, 2007, ChemMedChem.

Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity.

K. G. Jensen, K. Bogeso, J. Hyttel, 1988, Journal of medicinal chemistry.

Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].

K. Bogeso, P. Krogsgaard‐Larsen, B. Ebert, 1994, Journal of medicinal chemistry.

Muscarinic agonists. Syntheses and structure-activity relationships of bicyclic isoxazole ester bioisosteres of norarecoline

K. Bogeso, P. Krogsgaard‐Larsen, H. Pedersen, 1995 .

THE DEFIBRILLATING EFFECT OF CATECHOLAMINE REUPTAKE INHIBITORS

K. Bogeso, M. Erez, M. Manoach, 1993, Journal of basic and clinical physiology and pharmacology.

Highly potent indanamine serotonin uptake blockers as radiotracers for imaging serotonin uptake sites.

K. Bogeso, R. Dannals, H. Ravert, 1994, Nuclear medicine and biology.

Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.

K. Bogeso, J. Hyttel, J. Arnt, 1995, Journal of medicinal chemistry.

In vivo pharmacology of irindalone, a 5‐HT2 receptor antagonist with predominant peripheral effects

K. Bogeso, J. Hyttel, J. Arnt, 1989 .

Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.

K. Bogeso, P. Krogsgaard‐Larsen, B. Bang-Andersen, 1997, Journal of medicinal chemistry.

Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans.

K. Bogeso, 1983, Journal of medicinal chemistry.

A structure-activity study of four dopamine D-1 and D-2 receptor antagonists, representing the phenylindan, -indene, and -indole structural classes of compounds.

K. Bogeso, T. Liljefors, K P Bøgesø, 1993, Journal of medicinal chemistry.

The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer

K. Bogeso, J. Hyttel, J. Perregaard, 2005, Journal of Neural Transmission / General Section JNT.

Escitalopram versus citalopram: the surprising role of the R-enantiomer

K. Bogeso, C. Sánchez, C. Braestrup, 2004, Psychopharmacology.

Pharmacokinetic studies on clopenthixol decanoate; a comparison with clopenthixol in dogs and rats.

K. Bogeso, K. Overø, A. Jørgensen, 2009, Acta pharmacologica et toxicologica.

Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade

L. Tecott, K. Bogeso, B. Westerink, 2004, Neuropsychopharmacology.

Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles.

K. Bogeso, J. Hyttel, J. Arnt, 1992, Journal of medicinal chemistry.

Synthesis and Positron Emission Tomography Evaluation of Three Norepinephrine Transporter Radioligands: [C-11]Desipramine, [C-11]Talopram and [C-11]Talsupram

B. Gulyás, K. Bogeso, C. Halldin, 2005, Molecular Imaging and Biology.

Drug hunting : the medicinal chemistry of 1-piperazino-3-phenylindans and related compounds

K. Bogeso, 1998 .

Development of a receptor-interaction model for serotonin 5-HT2 receptor antagonists. Predicting selectivity with respect to dopamine D2 receptors.

K. Gundertofte, K. Bogeso, T. Liljefors, 1994, Journal of medicinal chemistry.

The Discovery of Citalopram and Its Refinement to Escitalopram

K. Bogeso, C. Sánchez, 2012 .

Strategies for pharmacotherapy of schizophrenia

K. Bogeso, B. Bang-Andersen, J. Arnt, 2008 .

New Trends in Antidepressant Drug Research

J. Kehler, K. Bogeso, C. Sánchez, 2017 .

Molecular Dynamics Simulations of Na+/Cl−‐Dependent Neurotransmitter Transporters in a Membrane‐Aqueous System

Anne Marie Jørgensen, K. Bogeso, G. Peters, 2007, ChemMedChem.

Neurochemical profile in vitro of irindalone: A5‐HT2‐receptor antagonist

K. Bogeso, J. Larsen, J. Hyttel, 1988 .

Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.

K. Bogeso, J. Hyttel, J. Arnt, 1988, Pharmacology & toxicology.

Exploration of insights, opportunities and caveats provided by the X-ray structures of hSERT.

K. Bogeso, C. Sánchez, B. Bang-Andersen, 2016, Bioorganic & medicinal chemistry letters.

Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity.

K. Bogeso, H. Pedersen, E. Meier, 1994, Journal of medicinal chemistry.

Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model.

K. Bogeso, T. Liljefors, A. Carlsson, 1990, Journal of medicinal chemistry.

Indolizidine and quinolizidine derivatives of the dopamine autoreceptor agonist 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP).

K. Bogeso, S. Sundell, J. Arnt, 1987, Journal of Medicinal Chemistry.

Conformational analysis and structural comparisons of (1R,3S)-(+)- and (1S,3R)-(-)-tefludazine, (S)-(+)- and (R)-(-)-octoclothepin, and (+)-dexclamol in relation to dopamine receptor antagonism and amine-uptake inhibition.

K. Bogeso, T. Liljefors, K P Bøgesø, 1988, Journal of medicinal chemistry.

Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters

S. Toubro, K. Bogeso, A. Bond, 2011, Proceedings of the National Academy of Sciences.

Neurochemical and behavioural profile of Lu 17‐133, (±)‐trans‐4‐[3‐(3,4‐dichlorophenyl)‐indan‐1‐yl]‐1‐piperazineethanol, an inhibitor of the uptake of dopamine and noradrenaline

K. Bogeso, J. Larsen, J. Hyttel, 1988 .

Stereospecific and selective 5-HT2 antagonism in a series of 5-substituted trans-1-piperazino-3-phenylindans.

K. Bogeso, J. Hyttel, J. Arnt, 1993, Journal of medicinal chemistry.

THIP, isoguvacine, isoguvacine oxide, and related GABA agonists.

K. Bogeso, P. Krogsgaard‐Larsen, T. Aaes-Jørgensen, 1981, Advances in biochemical psychopharmacology.